Treatment of Mycoplasma pneumonia by erythromycin and azithromycin: a comparison of the therapeutic effects and follow-up of cases
ZHANG Bing
Abstract No abstract available
Cite this article:
ZHANG Bing. Treatment of Mycoplasma pneumonia by erythromycin and azithromycin: a comparison of the therapeutic effects and follow-up of cases[J]. 中国当代儿科杂志, 2001, 3(6): 695-696.
ZHANG Bing. Treatment of Mycoplasma pneumonia by erythromycin and azithromycin: a comparison of the therapeutic effects and follow-up of cases[J]. CJCP, 2001, 3(6): 695-696.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2001/V3/I6/695
[1]
CAO Li-Jie, LIU Jian-Hua, SHUAI Jin-Feng, NIU Bo, LU Su-Kun, HUANG Kun-Ling. Efficacy of early treatment via fiber bronchoscope in children with Mycoplasma pneumoniae pneumonia complicated by airway mucus obstruction [J]. CJCP, 2018, 20(4): 298-302.
[2]
CHEN Qi-Fen, ZHANG Yi-Wei. Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia [J]. CJCP, 2018, 20(2): 116-120.
[3]
XU Jiang-Jiang, SHU Lin-Hua. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children [J]. CJCP, 2018, 20(1): 37-42.
[4]
LIU Jin, YAN Hong, CHEN Xiao-Geng, MU Ya-Ping. Effects of Huaiqihuang granules on immune function in children with severe Mycoplasma pneumoniae pneumonia [J]. CJCP, 2017, 19(7): 759-762.
[5]
ZHANG Lei, AN Mei-Yu, ZHU Bing, SHEN Wan-Dong, TAN Shu-Jiang, JI Xiao-Juan, TIAN Jie, LIU Xiao-Yan. Screening and follow-up for congenital heart disease in children aged 0-3 years in rural areas of Chongqing, China [J]. CJCP, 2017, 19(7): 748-753.
[6]
ZHANG Teng-Wei, LIN Fa-Tao, SONG Yan-Yan, WANG Lan-Xiu, CAI Yue-Ju. Early intellectual developmental outcome of late preterm infants [J]. CJCP, 2017, 19(2): 142-146.
[7]
ZHANG Qiong, WU Yun-Qin, ZHUANG Yan, CAO Jing, GAO Xi-Rong. Neurodevelopmental outcomes of extremely low birth weight and very low birth weight infants and related influencing factors [J]. CJCP, 2016, 18(8): 683-687.
[8]
GU Wen-Jing, ZHANG Xin-Xing, CHEN Zheng-Rong, YAN Yong-Dong, ZHU Can-Hong, HUANG Li, WANG Mei-Juan, SHAO Xue-Jun, JI Wei. Clinical significance of MP-DNA from endotracheal aspirates in diagnosis of Mycoplasma pneumoniae pneumonia in children [J]. CJCP, 2015, 17(9): 937-941.
[9]
AN Shu-Hua, ZHANG Li-Jun, LI Jin-Ying. Prognostic judgment of children with Mycoplasma pneumoniae pneumonia associated with airway mucous plug formation [J]. CJCP, 2015, 17(5): 487-491.
[10]
XIAO Yun-Bin, CHEN Zhi, HUANG Xi-Yong, WANG Xiang, WANG Xun, YANG Zhou. Transcatheter closure in various types of congenital coronary artery fistula: a followup study [J]. CJCP, 2015, 17(4): 384-389.
[11]
WANG Zhen, LI Ya-Chun, CHEN Lu. Early identification of refractory Mycoplasma pneumoniae pneumonia in children [J]. CJCP, 2015, 17(11): 1189-1192.
[12]
MA Xiang, DING Ming-Jie, ZHAO Xiu-Xia, SUN Jing, YANG Jin-Zhi, HAN Yu-Ling. Features of lung dysfunction in children with Mycoplasma pneumoniae pneumonia with different chest imaging findings [J]. CJCP, 2014, 16(10): 997-1000.
[13]
TIAN Fang, HAN Bo, DUAN Mei. Serum tumor necrosis factor-α, interleukin -6 and galctin-3 concentrations in children with Mycoplasma pneumoniae pneumonia [J]. CJCP, 2014, 16(10): 1001-1004.
[14]
GUO Shan-Chun, XU Chuan-Wei, LIU Yu-Qin, WANG Jia-Fen, ZHENG Zhen-Wen. Changes in plasma levels of thrombomodulin and D-dimer in children with different types of Mycoplasma pneumoniae pneumonia [J]. CJCP, 2013, 15(8): 619-622.
[15]
XU Yi, LIN Ping, WANG Cheng, WU Li-Jia, KANG Mei-Hua, ZHU Li-Ping, LI Fang, LI Yun-Li, CHU Wei-Hong, RAN Jing. Investigation of 24-hour blood pressure monitoring for evaluating treatment outcome of nerve-mediated syncope in children [J]. CJCP, 2013, 15(6): 458-461.